Published in Cancer Weekly, July 31st, 2001
The results of this and two related studies were announced June 26, 2001, at the 48th Society of Nuclear Medicine annual meeting in Toronto, Canada. The study by researchers at NYU found that ProstaScint imaging, when combined or fused with MRI (magnetic resonance imaging) or CT (computed tomography) scans in a digital overlay, offers a more specific evaluation of prostate...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.